Compare $BOLT vs $MTVA | Chartloom

Compare

$BOLT vs $MTVA

Bolt Biotherapeutics Inc · MetaVia Inc

BOLT

Bolt Biotherapeutics Inc

MTVA

MetaVia Inc

Compare $BOLT vs $MTVA

Comparing Bolt Biotherapeutics Inc and MetaVia Inc

BOLTBolt Biotherapeutics Inc

MTVAMetaVia Inc

BOLTBolt Biotherapeutics Inc

Market cap

$8M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

12.8%

YTD performance

-29.0%

52W performance

-35.8%

FCF yield

-399.6%

MTVAMetaVia Inc

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-85.3%

52W performance

-88.1%

FCF yield

-217.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BOLT

MTVA

Detailed metrics comparison

BOLT

Bolt Biotherapeutics Inc

MTVA

MetaVia Inc

Market Cap

BOLT$8M

MTVA$7M

Enterprise Value

BOLT$-5M

MTVA$-5M

Price

BOLT$4.11

MTVA$1.41

P/E Ratio

BOLTN/A

MTVAN/A

P/S Ratio

BOLT1.68x

MTVA0.00x

EV/Sales

BOLT-1.06x

MTVA0.00x

EV/EBITDA

BOLT0.00x

MTVA0.00x

P/B Ratio

BOLT0.53x

MTVA1.49x

P/FCF Ratio

BOLTN/A

MTVAN/A

EV/FCF

BOLT0.16x

MTVA0.34x

PEG Ratio

BOLTN/A

MTVAN/A

Forward P/E (NTM)

BOLTN/A

MTVAN/A

Forward P/S (NTM)

BOLTN/A

MTVAN/A

Revenue (TTM)

BOLT$5M

MTVA$0

Revenue Growth (YoY)

BOLT12.8%

MTVAN/A

Forward Rev Growth

BOLT1650.0%

MTVA149.6%

Gross Margin (TTM)

BOLT0.0%

MTVA0.0%

Operating Margin (TTM)

BOLT0.0%

MTVA0.0%

EBITDA Margin (TTM)

BOLT-586.3%

MTVA0.0%

Net Margin (TTM)

BOLT-611.5%

MTVA0.0%

FCF Margin (TTM)

BOLT-671.0%

MTVAN/A

Net Income (TTM)

BOLT$-29M

MTVA$-14M

FCF (TTM)

BOLT$-32M

MTVA$-16M

EPS (TTM)

BOLT-$17.00

MTVA-$2.44

ROE (TTM)

BOLT-12623.0%

MTVA-20967.0%

ROA (TTM)

BOLT-5470.0%

MTVA-10791.0%

ROIC (TTM)

BOLT-12623.0%

MTVA-20967.0%

Cash

BOLT$13M

MTVA$13M

Debt

BOLT$0

MTVA$0

Net Cash/Debt

BOLT$13M

MTVA$13M

Current Ratio (TTM)

BOLT2.61x

MTVA2.06x

Quick Ratio (TTM)

BOLT2.26x

MTVA2.04x

Debt/Equity (TTM)

BOLT0.00x

MTVA0.00x

Debt/Assets (TTM)

BOLT0.0%

MTVA0.0%

Interest Coverage (TTM)

BOLTN/A

MTVAN/A

Net Debt/EBITDA (TTM)

BOLT0.00x

MTVA0.00x

Beta

BOLT0.97

MTVA1.19

52W Performance

BOLT-35.8%

MTVA-88.1%

YTD Performance

BOLT-29.0%

MTVA-85.3%

% from 52W High

BOLT-42.9%

MTVA-90.5%

% from 52W Low

BOLT32.6%

MTVA45.4%

Asset Turnover (TTM)

BOLT0.09x

MTVA0.00x

FCF Yield (TTM)

BOLT-399.6%

MTVA-217.6%

Earnings Yield (TTM)

BOLT-364.2%

MTVA-198.6%

Dividend Yield (TTM)

BOLTN/A

MTVAN/A

Rule of 40

BOLT-658.2

MTVA0.0

EV/GP/RG

BOLTN/A

MTVAN/A

Ticker research

View BOLT research View MTVA research

Metric	BOLT Bolt Biotherapeutics Inc	MTVA MetaVia Inc
Market & Valuation
Market Cap	$8M	$7M
Enterprise Value	$-5M	$-5M
Price	$4.11	$1.41
P/E Ratio	N/A	N/A
P/S Ratio	1.68x	0.00x
EV/Sales	-1.06x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.53x	1.49x
P/FCF Ratio	N/A	N/A
EV/FCF	0.16x	0.34x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$5M	$0
Revenue Growth (YoY)	12.8%	N/A
Forward Rev Growth	1650.0%	149.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-586.3%	0.0%
Net Margin (TTM)	-611.5%	0.0%
FCF Margin (TTM)	-671.0%	N/A
Net Income (TTM)	$-29M	$-14M
FCF (TTM)	$-32M	$-16M
EPS (TTM)	-$17.00	-$2.44
ROE (TTM)	-12623.0%	-20967.0%
ROA (TTM)	-5470.0%	-10791.0%
ROIC (TTM)	-12623.0%	-20967.0%
Financial Health
Cash	$13M	$13M
Debt	$0	$0
Net Cash/Debt	$13M	$13M
Current Ratio (TTM)	2.61x	2.06x
Quick Ratio (TTM)	2.26x	2.04x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.97	1.19
52W Performance	-35.8%	-88.1%
YTD Performance	-29.0%	-85.3%
% from 52W High	-42.9%	-90.5%
% from 52W Low	32.6%	45.4%
Efficiency & Yields
Asset Turnover (TTM)	0.09x	0.00x
FCF Yield (TTM)	-399.6%	-217.6%
Earnings Yield (TTM)	-364.2%	-198.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-658.2	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BOLT research	View MTVA research

Valuation

P/S Ratio

MTVA

0.00x

BOLT

1.68x

EV/FCF

BOLT

0.16x

MTVA

0.34x

Growth & revenue

Revenue Growth TTM

BOLT

12.8%

Forward Revenue Growth

BOLT

1650.0%

MTVA

149.6%

Profitability & performance

Gross Margin

BOLT

0.0%

MTVA

0.0%

ROE

BOLT

-12623.0%

MTVA

-20967.0%

FCF Yield %

MTVA

-217.6%

BOLT

-399.6%

52-Week Performance

BOLT

-35.8%

MTVA

-88.1%

Detailed metrics comparison

BOLT

Bolt Biotherapeutics Inc

MTVA

MetaVia Inc

Market Cap

BOLT$8M

MTVA$7M

Enterprise Value

BOLT$-5M

MTVA$-5M

Price

BOLT$4.11

MTVA$1.41

P/E Ratio

BOLTN/A

MTVAN/A

P/S Ratio

BOLT1.68x

MTVA0.00x

EV/Sales

BOLT-1.06x

MTVA0.00x

EV/EBITDA

BOLT0.00x

MTVA0.00x

P/B Ratio

BOLT0.53x

MTVA1.49x

P/FCF Ratio

BOLTN/A

MTVAN/A

EV/FCF

BOLT0.16x

MTVA0.34x

PEG Ratio

BOLTN/A

MTVAN/A

Forward P/E (NTM)

BOLTN/A

MTVAN/A

Forward P/S (NTM)

BOLTN/A

MTVAN/A

Revenue (TTM)

BOLT$5M

MTVA$0

Revenue Growth (YoY)

BOLT12.8%

MTVAN/A

Forward Rev Growth

BOLT1650.0%

MTVA149.6%

Gross Margin (TTM)

BOLT0.0%

MTVA0.0%

Operating Margin (TTM)

BOLT0.0%

MTVA0.0%

EBITDA Margin (TTM)

BOLT-586.3%

MTVA0.0%

Net Margin (TTM)

BOLT-611.5%

MTVA0.0%

FCF Margin (TTM)

BOLT-671.0%

MTVAN/A

Net Income (TTM)

BOLT$-29M

MTVA$-14M

FCF (TTM)

BOLT$-32M

MTVA$-16M

EPS (TTM)

BOLT-$17.00

MTVA-$2.44

ROE (TTM)

BOLT-12623.0%

MTVA-20967.0%

ROA (TTM)

BOLT-5470.0%

MTVA-10791.0%

ROIC (TTM)

BOLT-12623.0%

MTVA-20967.0%

Cash

BOLT$13M

MTVA$13M

Debt

BOLT$0

MTVA$0

Net Cash/Debt

BOLT$13M

MTVA$13M

Current Ratio (TTM)

BOLT2.61x

MTVA2.06x

Quick Ratio (TTM)

BOLT2.26x

MTVA2.04x

Debt/Equity (TTM)

BOLT0.00x

MTVA0.00x

Debt/Assets (TTM)

BOLT0.0%

MTVA0.0%

Interest Coverage (TTM)

BOLTN/A

MTVAN/A

Net Debt/EBITDA (TTM)

BOLT0.00x

MTVA0.00x

Beta

BOLT0.97

MTVA1.19

52W Performance

BOLT-35.8%

MTVA-88.1%

YTD Performance

BOLT-29.0%

MTVA-85.3%

% from 52W High

BOLT-42.9%

MTVA-90.5%

% from 52W Low

BOLT32.6%

MTVA45.4%

Asset Turnover (TTM)

BOLT0.09x

MTVA0.00x

FCF Yield (TTM)

BOLT-399.6%

MTVA-217.6%

Earnings Yield (TTM)

BOLT-364.2%

MTVA-198.6%

Dividend Yield (TTM)

BOLTN/A

MTVAN/A

Rule of 40

BOLT-658.2

MTVA0.0

EV/GP/RG

BOLTN/A

MTVAN/A

Ticker research

View BOLT research View MTVA research

Metric	BOLT Bolt Biotherapeutics Inc	MTVA MetaVia Inc
Market & Valuation
Market Cap	$8M	$7M
Enterprise Value	$-5M	$-5M
Price	$4.11	$1.41
P/E Ratio	N/A	N/A
P/S Ratio	1.68x	0.00x
EV/Sales	-1.06x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.53x	1.49x
P/FCF Ratio	N/A	N/A
EV/FCF	0.16x	0.34x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$5M	$0
Revenue Growth (YoY)	12.8%	N/A
Forward Rev Growth	1650.0%	149.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-586.3%	0.0%
Net Margin (TTM)	-611.5%	0.0%
FCF Margin (TTM)	-671.0%	N/A
Net Income (TTM)	$-29M	$-14M
FCF (TTM)	$-32M	$-16M
EPS (TTM)	-$17.00	-$2.44
ROE (TTM)	-12623.0%	-20967.0%
ROA (TTM)	-5470.0%	-10791.0%
ROIC (TTM)	-12623.0%	-20967.0%
Financial Health
Cash	$13M	$13M
Debt	$0	$0
Net Cash/Debt	$13M	$13M
Current Ratio (TTM)	2.61x	2.06x
Quick Ratio (TTM)	2.26x	2.04x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.97	1.19
52W Performance	-35.8%	-88.1%
YTD Performance	-29.0%	-85.3%
% from 52W High	-42.9%	-90.5%
% from 52W Low	32.6%	45.4%
Efficiency & Yields
Asset Turnover (TTM)	0.09x	0.00x
FCF Yield (TTM)	-399.6%	-217.6%
Earnings Yield (TTM)	-364.2%	-198.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-658.2	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BOLT research	View MTVA research